Characteristics and Clinical Outcomes After Osteochondral Allograft Transplantation for Treating Articular Cartilage Defects: Systematic Review and Single-Arm Meta-analysis of Studies From 2001 to 2020

Xueding Wang; Zhiyuan Ren; Yang Liu; Yongsheng Ma; Lingan Huang; Wenjie Song; Qitai Lin; Zhipeng Zhang; Pengcui Li; Xiaochun Wei; Wangping Duan

doi:10.1177/23259671231199418

Characteristics and Clinical Outcomes After Osteochondral Allograft Transplantation for Treating Articular Cartilage Defects: Systematic Review and Single-Arm Meta-analysis of Studies From 2001 to 2020

Orthop J Sports Med. 2023 Sep 21;11(9):23259671231199418. doi: 10.1177/23259671231199418. eCollection 2023 Sep.

Authors

Xueding Wang^{1

2}, Zhiyuan Ren^{1

2}, Yang Liu^{1

2}, Yongsheng Ma^{1

2}, Lingan Huang², Wenjie Song^{1

2}, Qitai Lin^{1

2}, Zhipeng Zhang^{1

2}, Pengcui Li², Xiaochun Wei², Wangping Duan^{1

2}

Affiliations

¹ Department of Orthopaedics, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
² Shanxi Key Laboratory of Bone and Soft Tissue Injury Repair, Taiyuan, Shanxi, China.

Abstract

Background: Osteochondral allograft transplantation (OCA) treats symptomatic focal cartilage defects with satisfactory clinical results.

Purpose: To comprehensively analyze the characteristics and clinical outcomes of OCA for treating articular cartilage defects.

Study design: Systematic review; Level of evidence, 4.

Methods: We searched Embase, PubMed, Cochrane Database, and Web of Science for studies published between January 1, 2001, and December 31, 2020, on OCA for treating articular cartilage defects. Publication information, patient data, osteochondral allograft storage details, and clinical outcomes were extracted to conduct a comprehensive summative analysis.

Results: In total, 105 studies involving 5952 patients were included. The annual reported number of patients treated with OCA increased from 69 in 2001 to 1065 in 2020, peaking at 1504 cases in 2018. Most studies (90.1%) were performed in the United States. The mean age at surgery was 34.2 years, and 60.8% of patients were male and had a mean body mass index of 26.7 kg/m². The mean lesion area was 5.05 cm², the mean follow-up duration was 54.39 months, the mean graft size was 6.85 cm², and the number of grafts per patient was 54.7. The failure rate after OCA was 18.8%, and 83.1% of patients reported satisfactory results. Allograft survival rates at 2, 5, 10, 15, 20, and 25 years were 94%, 87.9%, 80%, 73%, 55%, and 59.4%, respectively. OCA was mainly performed on the knee (88.9%). The most common diagnosis in the knee was osteochondritis dissecans (37.9%), and the most common defect location was the medial femoral condyle (52%). The most common concomitant procedures were high tibial osteotomy (28.4%) and meniscal allograft transplantation (24.7%). After OCA failure, 54.7% of patients underwent revision with primary total knee arthroplasty.

Conclusion: The annual reported number of patients who underwent OCA showed a significant upward trend, especially from 2016 to 2020. Patients receiving OCA were predominantly young male adults with a high body mass index. OCA was more established for knee cartilage than an injury at other sites, and its best indication was osteochondritis dissecans. This analysis demonstrated satisfactory long-term postoperative outcomes.

Keywords: articular cartilage defect; cartilage repair; osteochondral allograft transplantation; systematic review.